Astria Therapeutics
ATXS
ATXS
62 hedge funds and large institutions have $14.2M invested in Astria Therapeutics in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.44% less ownership
Funds ownership: 7.2% → 5.77% (-1.4%)
72% less capital invested
Capital invested by funds: $51M → $14.2M (-$36.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
62
Holding in Top 10
–
Calls
$397K
Puts
$220K
Top Buyers
| 1 | +$1.39M | |
| 2 | +$1.33M | |
| 3 | +$1.12M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$402K |
| 5 |
State Street
Boston,
Massachusetts
|
+$266K |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$2.29M | |
| 3 | -$1.77M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$901K |
| 5 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$435K |